Request an update
Only fill in what should change. Everything you leave empty stays exactly as it is.
Current information
Organisation name
FimmCyte AG
Proposed update
Website
https://fimmcyte.com/
Positioning statement
Biotechnology company developing targeted immunotherapies for chronic fibro-inflammatory diseases, with a lead candidate for endometriosis.
What the organisation does
FimmCyte is conducting research and development on FMC2 with Gedeon Richter to move the candidate towards clinical testing. The agreement gives Richter an exclusive global option to license the therapy before the first-in-human trial.
City
Basel
Canton
BS
Company stage
Pilot / Validation
LinkedIn
—
The published profile stays visible until an editor approves.
